✦ LIBER ✦

Current and future treatment options in osteoporosis

✍ Scribed by Linda Brewer; David Williams; Alan Moore

Publisher: Springer
Year: 2011
Tongue: English
Weight: 262 KB
Volume: 67
Category: Article
ISSN: 0031-6970
DOI: 10.1007/s00228-011-0999-2

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Current, new and future treatments of os

Current, new and future treatments of osteoporosis

✍ Pooneh Salari Sharif; Mohammad Abdollahi; Bagher Larijani 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 333 KB

LUTS treatment: Future treatment options

✍ K.-E. Andersson 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 428 KB

Current treatment options in dermatofibr

Current treatment options in dermatofibrosarcoma protuberans

✍ Doreen Lemm; L.-O. Mügge; T. Mentzel; K. Höffken 📂 Article 📅 2009 🏛 Springer-Verlag 🌐 English ⚖ 542 KB

Idiopathic Inflammatory Myopathies: Curr

Idiopathic Inflammatory Myopathies: Current and Future Therapeutic Options

✍ Heinz Wiendl 📂 Article 📅 2008 🏛 Springer-Verlag 🌐 English ⚖ 100 KB

Osteoporosis: Current approaches and fut

Osteoporosis: Current approaches and future prospects in diagnosis, pathogenesis, and management

✍ Lawrence G. Raisz 📂 Article 📅 1999 🏛 Springer 🌐 English ⚖ 150 KB

Current and emerging treatment options i

Current and emerging treatment options in chronic myeloid leukemia

✍ Elias Jabbour; Jorge E. Cortes; Francis J. Giles; Susan O'Brien; Hagop M. Kantar 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 210 KB

## Abstract Treatments for chronic myeloid leukemia (CML) represent a success story in molecular medicine. The development of imatinib, a tyrosine kinase inhibitor (TKI) targeted against the causative Bcr‐Abl oncoprotein in CML, has resulted in hematologic and cytogenetic remissions in all phases o